Karl Schmieder

Things Karl Says on Podcasts

Founder and CEO of Messaginglab, with a pharmaceutical marketing background that includes launching Risperdal, Januvia and Lucentis. Co-author of What's Your Bio-Strategy? Preparing Your Business for Synthetic Biology. Hosts the Grow Everything Biotech Podcast with Erum Azeez Khan, interviewing founders and executives on biomanufacturing, synthetic biology and the bioeconomy. Has also appeared as a guest on Biotech Bytes.

Where to Find Them

Karl Schmieder hosts Grow Everything Biotech Podcast . They have also been a guest on Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders .

Recently: “207. Bio-Made in the USA: Jill Zullo Builds Domestic Scale at BioMADE” on Grow Everything Biotech Podcast (November 2026); “206. No Longer Lost in Translation: Anna Marie & Renee Decode the Bench at Transfyr” on Grow Everything Biotech Podcast (November 2026); “205. The Sweet Taste of Negative Waste: Max Kufner Ferments Carbon Waste at Again” on Grow Everything Biotech Podcast (October 2026); “204. Moore's Law Than Meets the Eye: Michael Wright's Blueprint at Biomimetics International” on Grow Everything Biotech Podcast (October 2026); “203. The Valley of Do: Karl & Erum Orchestrate Bio-Ecosystems at Bioinnovations Conference” on Grow Everything Biotech Podcast (October 2026); “202. Setting Sail for Biotech Scale: Jenny Rooke Steers Innovators at Genoa Venture” on Grow Everything Biotech Podcast (October 2026).

What They Said

“It's no longer the two-person biotech company. It's now the one-person biotech and the one-person virtual biotech company. So imagine what someone in Guatemala could do with these tools to solve a disease that is local.” — Karl Schmieder, Grow Everything Biotech Podcast

The hosts were discussing Anthropic's acquisition of a one-person AI-driven drug company. Karl argues that AI tools turn the one-person biotech into a repeatable model.

Grow Everything Biotech Podcast · 2026-11-13 Permalink → Listen →
Grow Everything Biotech Podcast Around 11:26 into the episode
Karl Schmieder

…going for rare muscular dystrophies. What motivated him to go into that? Because it's just one of those things that it's rare. Like those are rare diseases. And to be so focused on that, and apparently he coordinated 11 external laboratories and part-time consultants. I mean, it's just amazing.

Erum Azeez Khan

…if you are a biotech founder listening to this, this is a case study you really need to spend time digging into and seeing how it all came together. I mean, I'm sure there's lots of decision points that aren't shared publicly, but you're going to have to do the mental gymnastics to figure it out.

Karl Schmieder

Yeah, I mean, it's no longer the two-person biotech company. It's now the one-person biotech and the one-person virtual biotech company. So imagine what someone in Guatemala could do with these tools to solve a disease that is local. I think that this is super exciting. And there's a venture capitalist whose name I forget, who I follow on Instagram. And he's like, we're going to see every deck that involves someone looking for funding for drugs is going to mention how they're using these tools and are accelerating what they're doing. And I see it.

Erum Azeez Khan

Yeah, I see it with the class I'm involved with. These students, we're getting very far in terms of developing products, but that's just, again, the technology is one aspect of it. You have to be able to go out into the world, talk to the people that need to help you build the product, and then to…

Karl Schmieder

Okay. So Iram, you started off by saying what the actual F is going on. Did you see this Warhound news?

Erum Azeez Khan

Oh my God. Oh my God. I don't even know what to say. It's actually really funny. No, not the story, which we're going to talk about, the Warhound, but I had someone text me and they're like, did you hear this news about Colossal? And they texted me right after we talked about the bird, that…

Speaker names come from our own diarization. The position is estimated from where the line sits in the episode.

Collections They Appear In